Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Non Operating Income (2016 - 2025)

Historic Non Operating Income for Palisade Bio (PALI) over the last 16 years, with Q3 2025 value amounting to $59000.0.

  • Palisade Bio's Non Operating Income fell 4732.14% to $59000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $242000.0, marking a year-over-year decrease of 5820.38%. This contributed to the annual value of $433000.0 for FY2024, which is 4484.08% down from last year.
  • As of Q3 2025, Palisade Bio's Non Operating Income stood at $59000.0, which was down 4732.14% from $61000.0 recorded in Q2 2025.
  • Palisade Bio's 5-year Non Operating Income high stood at $11.1 million for Q3 2021, and its period low was -$2.1 million during Q1 2021.
  • Moreover, its 5-year median value for Non Operating Income was $167000.0 (2023), whereas its average is $785666.7.
  • Per our database at Business Quant, Palisade Bio's Non Operating Income surged by 4122222.22% in 2021 and then plummeted by 9616.32% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's Non Operating Income stood at $11.1 million in 2021, then tumbled by 98.82% to $131000.0 in 2022, then skyrocketed by 42.75% to $187000.0 in 2023, then crashed by 78.07% to $41000.0 in 2024, then soared by 43.9% to $59000.0 in 2025.
  • Its last three reported values are $59000.0 in Q3 2025, $61000.0 for Q2 2025, and $81000.0 during Q1 2025.